About: Michigan Cancer Research Consortium

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Michigan Cancer Research Consortium Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

organization in Ann Arbor, United States

Attributes	Values
rdf:type	Item
description	organisatie uit Verenigde Staten van Amerika (nl) US-amerikanische Organisation (de) американська організація (uk) منظمة في آن آربر، الولايات المتحدة (ar) organization in Ann Arbor, United States (en)
rdfs:label	Michigan Cancer Research Consortium (en)
skos:prefLabel	Michigan Cancer Research Consortium (en)
name	Michigan Cancer Research Consortium (en)
ROR ID	wds:Q30269547-181F6A87-14FC-4DA3-975A-188997859254
ROR ID	02mfxyv79
instance of	wds:Q30269547-31C1AEA2-8F5A-4AB6-B9DB-9F96B6C09D2D
instance of	organization
country	wds:Q30269547-05C16260-858C-45B7-AB2A-872C838DE54B
country	United States of America
inception	wds:Q30269547-DA06202F-B6DE-49BE-8F18-E30D9760B919
inception	1983-01-01 00:00:00Z (xsd:dateTime)
skos:altLabel	MCRC (en) MCRC-NCORP (en) Michigan Cancer Research Consortium NCORP (en)
located in the adm...erritorial entity	wds:Q30269547-1232D44D-9784-4029-838E-8F55ED7BE5AF
coordinate location	wds:Q30269547-BB68B289-F4EF-4040-8285-5DB9E5301E63
official website	wds:Q30269547-A8C986AF-FB8F-4799-85F2-E07D658730E4
located in the adm...erritorial entity	Ann Arbor
coordinate location	POINT(-83.659798 42.263436)
official website	http://www.mcrconline.org/
GRID ID	wds:Q30269547-0E182906-38B3-4521-BAC4-514B77098779
GRID ID	grid.476969.3
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30269547
is research site of	Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers Soy Protein/Effexor Hormone Therapy for Prostate Cancer Methylphenidate in Treating Patients With Fatigue Caused by Cancer Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy Improving Communication in Older Cancer Patients and Their Caregivers Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme S9630, Medroxyprogesterone in Treating Women With Breast Cancer Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial S9925: Collecting and Storing Samples From Patients With Lung Cancer Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass Pregabalin in Treating Women With Hot Flashes S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Creatine in Treating Patients With Cancer-Associated Weight Loss Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer Epoetin Alfa in Treating Anemia in Patients With Solid Tumors Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software